Dr. Rachel Sanborn, MD
Claim this profileProvidence Portland Medical Center
About Rachel Sanborn, MD
Education:
- MD (Doctor of Medicine) from Oregon Health & Science University, completed in 2005.
Experience:
- Medical Oncologist at Providence Cancer Institute.
- Currently the Medical Director of the Gastrointestinal Oncology Program.
- Associate Professor of Medicine at Oregon Health & Science University.
- Actively involved in clinical research with numerous publications in peer-reviewed journals.
Area of expertise
Lung Cancer
Rachel Sanborn, MD has run 26 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Rachel Sanborn, MD has run 19 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Providence Portland Medical Center
Providence Cancer Institute
Clinical Trials Rachel Sanborn, MD is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting
1 award
Phase 3
14 criteria
IPG7236
for Advanced Cancer
This trial tests a new drug, IPG7236, in patients with advanced solid tumors to see if it is safe and can help shrink their tumors.
Recruiting
1 award
Phase 1 & 2
More about Rachel Sanborn, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 43 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Rachel Sanborn, MD has experience with
- Pembrolizumab
- Nivolumab
- Pemetrexed
- Carboplatin
- Atezolizumab
- Ipilimumab
Breakdown of trials Rachel Sanborn, MD has run
Non-Small Cell Lung Cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachel Sanborn, MD specialize in?
Rachel Sanborn, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Rachel Sanborn, MD currently recruiting for clinical trials?
Yes, Rachel Sanborn, MD is currently recruiting for 8 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Rachel Sanborn, MD has studied deeply?
Yes, Rachel Sanborn, MD has studied treatments such as Pembrolizumab, Nivolumab, Pemetrexed.
What is the best way to schedule an appointment with Rachel Sanborn, MD?
Apply for one of the trials that Rachel Sanborn, MD is conducting.
What is the office address of Rachel Sanborn, MD?
The office of Rachel Sanborn, MD is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.